Altria Client Services LLC
10
1
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
78%
7 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Changes in Biomarker of Exposure in Adults Who Smoke Cigarettes Switching From Cigarettes to Heated Tobacco Products
Role: lead
Pharmacokinetic and Subjective Effects of Heated Tobacco Products
Role: lead
Room Air Levels of Harmful and Potentially Harmful Constituents After Heated Tobacco Product Use and Cigarettes
Role: lead
Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products
Role: lead
Nicotine Pharmacokinetics and Subjective Effects of Oral Nicotine Products Relative to Smokeless Tobacco in Adult Users
Role: lead
Study to Evaluate Changes in Smokers Using on!® Nicotine Pouches
Role: lead
A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.
Role: lead
A Study to Evaluate Changes in Smokers Using An Oral Tobacco-Derived Nicotine Product
Role: lead
Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users
Role: lead
Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study
Role: lead
All 10 trials loaded